WntResearch AB (NGM:WNT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.4930
+0.0160 (3.35%)
Inactive · Last trade price on Apr 4, 2025
-92.64%
Market Cap 4.27M
Revenue (ttm) n/a
Net Income (ttm) -46.50M
Shares Out 8.67M
EPS (ttm) -5.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 101,498
Average Volume 86,248
Open 0.4000
Previous Close 0.4770
Day's Range 0.4000 - 0.4930
52-Week Range 0.4000 - 17.2000
Beta -0.21
RSI 43.17
Earnings Date May 2, 2025

About WntResearch AB

WntResearch AB, a biotech company, develops therapies to prevent the metastatic process. The company develops Foxy-5, a peptide, which is in Phase II clinical trials that reduced the risk of metastasis in patients with colon cancer. It is also developing Box-5, a WNT5A antagonist for the treatment of malignant melanoma, and pancreatic and gastric cancer. The company was incorporated in 2007 and is based in Lund, Sweden. [Read more]

Industry Other
Founded 2007
Employees 2
Stock Exchange Nordic Growth Market
Ticker Symbol WNT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.